Published by Josh White on 21st January 2021
(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced on Thursday that its collaboration with a prominent European university had generated "highly positive" data for 'SFX-01' in pre-clinical models of glioma and glioblastoma.
URL: http://www.digitallook.com/dl/news/story/31593199/...